Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR New Investigator

University of British Columbia

$300,000.00

Effects of Prescription Adaptation and Renewal by Pharmacists

EF 2009-10

Résumé
In January 2009, a policy change in British Columbia (BC) gave pharmacists the authority to independently modify and renew prescriptions. The policy is intended to improve patient access to drugs and reduce the already heavy burden on primary care physicians. However, physicians and others have raised concerns about potential negative effects on patient safety due to inappropriate medication modifications and reduced continuity of care. While several other provinces have either implemented or proposed similar policies, there have been conspicuously few rigorous evaluations of these changes. We will use the world-class health research datasets in BC to study the effects of this policy change on drug utilization and costs, patient adherence to medication, the number of visits to physicians and hospitalization. Our study will benefit Canadians by informing the future design and refinement of these important and controversial policies.
Programme
CIHR New Investigator
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
192145
Name
Law Michael R
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Health Research Salary A
Projecttitle
Effects of Prescription Adaptation and Renewal by Pharmacists
Programtype2
Salary Programs
Orgnameinp2
University of British Columbia
Cihramount2
$300,000
Cihrequipment2
$0
Programname2
CIHR New Investigator
Keyworddelim
Health Policy; Health Services Research; Observational Research; Pharmacare; Pharmaceutical Policy; Prescription Drugs
Abstract
In January 2009, a policy change in British Columbia (BC) gave pharmacists the authority to independently modify and renew prescriptions. The policy is intended to improve patient access to drugs and reduce the already heavy burden on primary care physicians. However, physicians and others have raised concerns about potential negative effects on patient safety due to inappropriate medication modifications and reduced continuity of care. While several other provinces have either implemented or proposed similar policies, there have been conspicuously few rigorous evaluations of these changes. We will use the world-class health research datasets in BC to study the effects of this policy change on drug utilization and costs, patient adherence to medication, the number of visits to physicians and hospitalization. Our study will benefit Canadians by informing the future design and refinement of these important and controversial policies.
Competitiondate
200909
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Law, Michael R
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $300,000~ $0~